Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Genetic toxicity: in vivo

Currently viewing:

Administrative data

Endpoint:
in vivo mammalian germ cell study: gene mutation
Remarks:
Type of genotoxicity: gene mutation
Type of information:
migrated information: read-across from supporting substance (structural analogue or surrogate)
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Meets generally accepted scientific standards, sufficiently documented and acceptable for assessment

Data source

Reference
Reference Type:
publication
Title:
Pulmonary chemokine and mutagenic responses in rats after subchronic inhalation of amorphous and crystalline silica.
Author:
Johnston, C.J. et al.
Year:
2000
Bibliographic source:
Toxicological Sciences 56, 405-413

Materials and methods

Principles of method if other than guideline:
Ex vivo (isolation of cells from treated animals) rat HPRT mutation assay with alveolar epithelial cells after 13 weeks inhalation exposure.
GLP compliance:
not specified
Type of assay:
endogenous gene animal assay

Test material

Constituent 1
Reference substance name:
Cristobalite
EC Number:
238-455-4
EC Name:
Cristobalite
Cas Number:
14464-46-1
IUPAC Name:
14464-46-1
Details on test material:
- Name of test material (as cited in study report): Cristobalite, crystalline silica
- Analytical purity: no data

Test animals

Species:
rat
Strain:
Fischer 344
Sex:
male

Administration / exposure

Route of administration:
inhalation: aerosol
Vehicle:
filtered air
Details on exposure:
TYPE OF INHALATION EXPOSURE: whole body


GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: compartmentalized 300-liters horizontal laminar flow chambers
- System of generating particulates/aerosols: a screw-feed mechanism in combination with a Venturi-type dust feeder.
Duration of treatment / exposure:
13 weeks
Frequency of treatment:
6 h/day, 5 days/week for 13 weeks
Post exposure period:
none
Doses / concentrations
Remarks:
Doses / Concentrations:
3 ± 1 mg/m3
Basis:
analytical conc.
No. of animals per sex per dose:
4
Control animals:
yes, concurrent vehicle

Examinations

Tissues and cell types examined:
rat alveolar type-II cells
Details of tissue and slide preparation:
METHOD OF ANALYSIS:
Selection for mutation in the HPRT gene in cells isolated from treated animals. Isolated cells were seeded in flasks. After removal of non-adherent cells, cell cultures were fed with selection medium containing 6-thioguanine (40 µM); cultures were refed every other day with 6-TG-containing medium. After 14 - 21 days in culture the cells were fixed and immunostained with an antibody to cytokeratins 8, 18 and 19 and 6-TG-resistant cytokeratin staining colonies of greater than 50 cells counted.
Statistics:
Analysis of variance. Differenced from the control group were determined using Dunnett's test. Statistical significance was considered at p < 0.05.

Results and discussion

Test results
Sex:
male
Genotoxicity:
positive
Toxicity:
not specified
Vehicle controls validity:
valid
Negative controls validity:
not examined
Positive controls validity:
valid

Any other information on results incl. tables

Mutation frequencies in the air control group were 7.6 ± 3.4 mutants/106 epithelial cells. Exposure to 3 mg/m3 crystalline silica resulted in HPRT mutation frequencies which were 4.3 -fold greater than the air control group, immediately after 13 weeks of exposure.

Applicant's summary and conclusion

Conclusions:
Interpretation of results (migrated information): positive